1-52033008-G-C

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_138417.3(KTI12):ā€‹c.754C>Gā€‹(p.Arg252Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000142 in 1,408,488 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: not found (cov: 33)
Exomes š‘“: 0.0000014 ( 0 hom. )

Consequence

KTI12
NM_138417.3 missense

Scores

3
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.38
Variant links:
Genes affected
KTI12 (HGNC:25160): (KTI12 chromatin associated homolog) Predicted to enable ATP binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II and tRNA wobble uridine modification. [provided by Alliance of Genome Resources, Apr 2022]
TXNDC12 (HGNC:24626): (thioredoxin domain containing 12) This gene encodes a member of the thioredoxin superfamily. Members of this family are characterized by a conserved active motif called the thioredoxin fold that catalyzes disulfide bond formation and isomerization. This protein localizes to the endoplasmic reticulum and has a single atypical active motif. The encoded protein is mainly involved in catalyzing native disulfide bond formation and displays activity similar to protein-disulfide isomerases. This protein may play a role in defense against endoplasmic reticulum stress. Alternate splicing results in both coding and non-coding variants. [provided by RefSeq, Mar 2012]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.22022608).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
KTI12NM_138417.3 linkuse as main transcriptc.754C>G p.Arg252Gly missense_variant 1/1 ENST00000371614.2 NP_612426.1 Q96EK9
TXNDC12NM_015913.4 linkuse as main transcriptc.159-4378C>G intron_variant ENST00000371626.9 NP_056997.1 O95881
TXNDC12NR_046405.1 linkuse as main transcriptn.2277C>G non_coding_transcript_exon_variant 3/3
TXNDC12NR_046406.1 linkuse as main transcriptn.2154C>G non_coding_transcript_exon_variant 3/3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
KTI12ENST00000371614.2 linkuse as main transcriptc.754C>G p.Arg252Gly missense_variant 1/16 NM_138417.3 ENSP00000360676.1 Q96EK9
TXNDC12ENST00000371626.9 linkuse as main transcriptc.159-4378C>G intron_variant 1 NM_015913.4 ENSP00000360688.4 O95881
ENSG00000285839ENST00000648686.1 linkuse as main transcriptn.343C>G non_coding_transcript_exon_variant 1/7 ENSP00000498140.1 A0A3B3IU88
TXNDC12ENST00000472624.5 linkuse as main transcriptn.159-2460C>G intron_variant 5 ENSP00000477120.1 V9GYV4

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
AF:
0.00000142
AC:
2
AN:
1408488
Hom.:
0
Cov.:
33
AF XY:
0.00000144
AC XY:
1
AN XY:
696146
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000261
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsOct 12, 2021The c.754C>G (p.R252G) alteration is located in exon 1 (coding exon 1) of the KTI12 gene. This alteration results from a C to G substitution at nucleotide position 754, causing the arginine (R) at amino acid position 252 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.16
T
BayesDel_noAF
Benign
-0.47
CADD
Uncertain
23
DANN
Uncertain
0.99
DEOGEN2
Benign
0.029
T
Eigen
Benign
0.12
Eigen_PC
Benign
0.16
FATHMM_MKL
Benign
0.37
N
LIST_S2
Benign
0.86
D
M_CAP
Benign
0.022
T
MetaRNN
Benign
0.22
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.9
M
PrimateAI
Benign
0.35
T
PROVEAN
Uncertain
-3.5
D
REVEL
Benign
0.060
Sift
Uncertain
0.029
D
Sift4G
Benign
0.076
T
Polyphen
0.58
P
Vest4
0.25
MutPred
0.52
Loss of methylation at R252 (P = 0.0497);
MVP
0.52
MPC
0.79
ClinPred
0.98
D
GERP RS
4.7
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.27
gMVP
0.46

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr1-52498680; API